CN107325163B - Astragalus seed protein and application thereof in anti-sports fatigue functional food - Google Patents
Astragalus seed protein and application thereof in anti-sports fatigue functional food Download PDFInfo
- Publication number
- CN107325163B CN107325163B CN201710580674.7A CN201710580674A CN107325163B CN 107325163 B CN107325163 B CN 107325163B CN 201710580674 A CN201710580674 A CN 201710580674A CN 107325163 B CN107325163 B CN 107325163B
- Authority
- CN
- China
- Prior art keywords
- astragalus
- saturation
- seed protein
- ammonium sulfate
- astragalus seed
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 235000006533 astragalus Nutrition 0.000 title claims abstract description 48
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 41
- 102000004169 proteins and genes Human genes 0.000 title claims abstract description 41
- 241001061264 Astragalus Species 0.000 title claims abstract description 39
- 210000004233 talus Anatomy 0.000 title claims abstract description 39
- 235000013376 functional food Nutrition 0.000 title claims abstract description 9
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 claims abstract description 27
- 229910052921 ammonium sulfate Inorganic materials 0.000 claims abstract description 27
- 235000011130 ammonium sulphate Nutrition 0.000 claims abstract description 27
- 239000006228 supernatant Substances 0.000 claims abstract description 17
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims abstract description 16
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims abstract description 16
- 238000000034 method Methods 0.000 claims abstract description 15
- 238000003756 stirring Methods 0.000 claims abstract description 14
- 239000000243 solution Substances 0.000 claims abstract description 12
- 239000002244 precipitate Substances 0.000 claims abstract description 10
- 235000013361 beverage Nutrition 0.000 claims abstract description 8
- 239000003208 petroleum Substances 0.000 claims abstract description 8
- 239000009636 Huang Qi Substances 0.000 claims abstract description 7
- 238000002386 leaching Methods 0.000 claims abstract description 7
- 239000007836 KH2PO4 Substances 0.000 claims abstract description 5
- 229910000402 monopotassium phosphate Inorganic materials 0.000 claims abstract description 5
- 239000007853 buffer solution Substances 0.000 claims abstract description 4
- 238000004108 freeze drying Methods 0.000 claims abstract description 4
- 239000007788 liquid Substances 0.000 claims abstract description 4
- 238000010298 pulverizing process Methods 0.000 claims abstract description 4
- 239000007787 solid Substances 0.000 claims abstract description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 9
- 238000000502 dialysis Methods 0.000 claims description 6
- 239000000843 powder Substances 0.000 claims description 4
- 238000005119 centrifugation Methods 0.000 claims description 3
- 239000008367 deionised water Substances 0.000 claims description 3
- 229910021641 deionized water Inorganic materials 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- 235000015895 biscuits Nutrition 0.000 claims description 2
- 239000000872 buffer Substances 0.000 claims description 2
- 238000005238 degreasing Methods 0.000 claims description 2
- 238000001914 filtration Methods 0.000 claims description 2
- 238000001556 precipitation Methods 0.000 abstract description 10
- 235000015872 dietary supplement Nutrition 0.000 abstract description 7
- 238000000605 extraction Methods 0.000 abstract description 7
- 238000000926 separation method Methods 0.000 abstract description 7
- 235000013305 food Nutrition 0.000 abstract description 3
- 235000014510 cooky Nutrition 0.000 abstract description 2
- 239000000284 extract Substances 0.000 abstract description 2
- 239000008280 blood Substances 0.000 description 24
- 210000004369 blood Anatomy 0.000 description 24
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 24
- 229920002527 Glycogen Polymers 0.000 description 21
- 229940096919 glycogen Drugs 0.000 description 21
- 241000699670 Mus sp. Species 0.000 description 17
- 230000009182 swimming Effects 0.000 description 15
- 239000004310 lactic acid Substances 0.000 description 12
- 235000014655 lactic acid Nutrition 0.000 description 12
- 230000000694 effects Effects 0.000 description 11
- 210000003205 muscle Anatomy 0.000 description 10
- 241000045403 Astragalus propinquus Species 0.000 description 9
- PNNCWTXUWKENPE-UHFFFAOYSA-N [N].NC(N)=O Chemical compound [N].NC(N)=O PNNCWTXUWKENPE-UHFFFAOYSA-N 0.000 description 9
- 210000004185 liver Anatomy 0.000 description 8
- 241000699666 Mus <mouse, genus> Species 0.000 description 6
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 6
- 238000011160 research Methods 0.000 description 5
- 230000000052 comparative effect Effects 0.000 description 4
- 230000007812 deficiency Effects 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- ZKHQWZAMYRWXGA-UHFFFAOYSA-N Adenosine triphosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)C(O)C1O ZKHQWZAMYRWXGA-UHFFFAOYSA-N 0.000 description 3
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 3
- 239000004202 carbamide Substances 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 208000006820 Arthralgia Diseases 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 230000002860 competitive effect Effects 0.000 description 2
- CVSVTCORWBXHQV-UHFFFAOYSA-N creatine Chemical compound NC(=[NH2+])N(C)CC([O-])=O CVSVTCORWBXHQV-UHFFFAOYSA-N 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- 238000010494 dissociation reaction Methods 0.000 description 2
- 230000005593 dissociations Effects 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- PHIQHXFUZVPYII-ZCFIWIBFSA-O (R)-carnitinium Chemical compound C[N+](C)(C)C[C@H](O)CC(O)=O PHIQHXFUZVPYII-ZCFIWIBFSA-O 0.000 description 1
- ZKHQWZAMYRWXGA-KQYNXXCUSA-J ATP(4-) Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)[C@H]1O ZKHQWZAMYRWXGA-KQYNXXCUSA-J 0.000 description 1
- 241000208340 Araliaceae Species 0.000 description 1
- 208000025978 Athletic injury Diseases 0.000 description 1
- 238000011740 C57BL/6 mouse Methods 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 206010007882 Cellulitis Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000220485 Fabaceae Species 0.000 description 1
- 208000012671 Gastrointestinal haemorrhages Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010019468 Hemiplegia Diseases 0.000 description 1
- 208000004044 Hypesthesia Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 229930010555 Inosine Natural products 0.000 description 1
- UGQMRVRMYYASKQ-KQYNXXCUSA-N Inosine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C2=NC=NC(O)=C2N=C1 UGQMRVRMYYASKQ-KQYNXXCUSA-N 0.000 description 1
- 208000016285 Movement disease Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 108010026552 Proteome Proteins 0.000 description 1
- 206010038084 Rectocele Diseases 0.000 description 1
- 206010041738 Sports injury Diseases 0.000 description 1
- 208000033809 Suppuration Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 229960001456 adenosine triphosphate Drugs 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 238000007605 air drying Methods 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000002929 anti-fatigue Effects 0.000 description 1
- 230000002180 anti-stress Effects 0.000 description 1
- 210000003056 antler Anatomy 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 235000019206 astragalus extract Nutrition 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 239000004227 calcium gluconate Substances 0.000 description 1
- 229960004494 calcium gluconate Drugs 0.000 description 1
- 235000013927 calcium gluconate Nutrition 0.000 description 1
- NEEHYRZPVYRGPP-UHFFFAOYSA-L calcium;2,3,4,5,6-pentahydroxyhexanoate Chemical compound [Ca+2].OCC(O)C(O)C(O)C(O)C([O-])=O.OCC(O)C(O)C(O)C(O)C([O-])=O NEEHYRZPVYRGPP-UHFFFAOYSA-L 0.000 description 1
- 229960004203 carnitine Drugs 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 208000019902 chronic diarrheal disease Diseases 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 229960003624 creatine Drugs 0.000 description 1
- 239000006046 creatine Substances 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000005611 electricity Effects 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000037080 exercise endurance Effects 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 230000034659 glycolysis Effects 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 208000034783 hypoesthesia Diseases 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 229960003786 inosine Drugs 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 230000005389 magnetism Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 238000001543 one-way ANOVA Methods 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 210000003899 penis Anatomy 0.000 description 1
- 238000000554 physical therapy Methods 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 238000001671 psychotherapy Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 230000000284 resting effect Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 210000002027 skeletal muscle Anatomy 0.000 description 1
- 230000012232 skeletal muscle contraction Effects 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
-
- A—HUMAN NECESSITIES
- A21—BAKING; EDIBLE DOUGHS
- A21D—TREATMENT, e.g. PRESERVATION, OF FLOUR OR DOUGH, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS; PRESERVATION THEREOF
- A21D13/00—Finished or partly finished bakery products
- A21D13/06—Products with modified nutritive value, e.g. with modified starch content
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/385—Concentrates of non-alcoholic beverages
- A23L2/39—Dry compositions
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/185—Vegetable proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Nutrition Science (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Botany (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Mycology (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The invention discloses an astragalus seed protein and application thereof in anti-sports fatigue functional food, and the extraction and separation method of the protein comprises the following steps: pulverizing radix astragali seed, defatting with petroleum ether, and adding KH2PO4Stirring and leaching the NaOH buffer solution for 6 to 12 hours to obtain an extracting solution; adding powdered ammonium sulfate into the extract to reach 30% saturation, centrifuging, and collecting supernatant; adding powdered ammonium sulfate to 80% saturation, centrifuging, and collecting precipitate; dialyzing the precipitate until the dialyzate is colorless, and finally freeze-drying to obtain the astragalus seed protein. The astragalus seed protein is prepared by an ammonium sulfate saturation precipitation method, and the saturation of the ammonium sulfate is 30-80%. Can be used as nutritional supplement for resisting sports fatigue, and can be added into cookies, liquid beverage, and solid beverage, with convenient use, and can satisfy sports people who like different food types.
Description
Technical Field
The invention belongs to the field of natural products and functional research thereof, and particularly relates to astragalus seed protein and application thereof in an anti-sports fatigue functional food.
Background
When the training and competition loads of athletes exceed the body's ability to withstand, temporary physiological hypofunction can occur. The physical inadaptation, called exercise fatigue, is caused by the physiological process failing to maintain the function of the body at a specific level or a predetermined exercise intensity. The sports fatigue is relieved, and the sports injury caused by excessive sports and extreme sports can be avoided or reduced in the field of competitive sports; in the field of public body building, the body metabolism disorder caused by the excessive sports fatigue can be avoided, and the internal secretion and the injury of internal organs and tissues can be avoided.
The common methods for relieving exercise-induced fatigue mainly comprise: (1) the sporter is actively rested or trained to recover the therapy; (2) physical therapy using physical stimuli such as light, electricity, magnetism, heat, force, etc. to accelerate microcirculation, promote metabolism, and eliminate fatigue; (3) nutritional supplement therapy for supplementing specific functional foods (free of stimulant substances prohibited by International Olympic Commission) prepared from protein, amino acids, creatine, carnitine, vitamins, minerals, etc.; (4) using various Chinese herbal medicines such as ginseng, penis, pilose antler and the like and chemical medicines such as calcium gluconate, inosine, adenosine triphosphate and the like for medicine conditioning; (5) psychotherapy with cueing, relaxation, breathing regulation, recreation and recreational activities. Among them, nutritional supplement foods made using proteins and amino acids for alleviating exercise-induced fatigue have received much attention from researchers.
Radix astragali is dried root of Astragalus membranaceus (Fisch) Bge. var. mongholicus (Bge) Hsiao) or Astragalus membranaceus (Fisch) Bge. of Leguminosae. Sweet in nature and slightly warm in taste. It enters lung and spleen meridians. Has the functions of invigorating qi, invigorating yang, consolidating superficial resistance, arresting sweating, inducing diuresis, relieving swelling, promoting fluid production, nourishing blood, activating stagnancy, relieving arthralgia, expelling toxin, expelling pus, healing sore and promoting granulation. Can be used for treating deficiency of vital energy, asthenia, anorexia, loose stool, collapse of middle-warmer energy, chronic diarrhea, rectocele, hematochezia, spontaneous perspiration due to exterior deficiency, edema due to qi deficiency, internal heat, diabetes, blood deficiency, hemiplegia, arthralgia, numbness, carbuncle, cellulitis, and intractable ulcer.
At present, the research on the astragalus extract is mainly focused on the astragalus medicinal material, namely the root of astragalus. Related researches on extracts derived from astragalus seeds are less reported, and researches on the anti-exercise fatigue efficacy of astragalus seed protein are not reported.
Disclosure of Invention
The invention aims at providing an extraction and separation method of astragalus seed protein, which is an ammonium sulfate saturation precipitation method, wherein the saturation degree of ammonium sulfate is 30-80%.
Another object of the present invention is to provide the seed protein of Astragalus membranaceus prepared by the above method.
The invention also aims to provide application of the astragalus membranaceus seed protein.
The purpose of the invention is realized by the following technical scheme:
an extraction and separation method of astragalus seed protein comprises the following steps:
(1) pulverizing radix astragali seed, defatting with petroleum ether, and adding KH2PO4Stirring and leaching the solution with NaOH buffer solution for 6 to 12 hours, centrifuging, and taking supernatant; repeating the above leaching operation for several times, and mixing the obtained supernatants to obtain extractive solution;
(2) slowly adding powdered ammonium sulfate into the extractive solution under stirring to 30% saturation, centrifuging, and collecting supernatant; slowly adding powdered ammonium sulfate into the supernatant under continuous stirring to reach 80% saturation, centrifuging, and collecting precipitate;
(3) transferring the precipitate into a dialysis bag, dialyzing in deionized water (changing water every 24h on average) until the dialysate is colorless, and freeze-drying the components in the dialysis bag to obtain astragalus seed protein;
the Astragalus seeds are dried seeds of Astragalus mongholicus (Fisch) Bge. var. mongholicus (Bge) Hsiao.) which is a leguminous plant (purchased from northern medicinal material seed company of Anguo city in Hebei province and identified by experts of Chinese academy of Guangdong pharmaceutical university);
the petroleum ether degreasing is to soak the astragalus seed powder for 2 to 4 hours in a sealed way by using petroleum ether, filtering, air-drying the astragalus seed powder, and recovering the filtrate by using a rotary evaporator;
the KH2PO4NaOH buffer, preferably at a concentration of 40mmol/L,the pH value is preferably 6.8-8.0;
the centrifugation is preferably 2000-3000r/min and 8-15 min;
the method is carried out in the environment of 4-10 ℃.
The astragalus seed protein prepared by the method has the function of resisting sports fatigue, can obviously prolong the swimming exhaustion time of a mouse, obviously reduces the blood lactic acid and blood urea nitrogen content of the mouse, and obviously increases the liver glycogen and muscle glycogen concentration of the mouse.
The astragalus seed protein is used for resisting sports fatigue of mice, the administration route is gastrointestinal tract route, the dosage is 0.1-5g/kg.d, preferably 0.5-2g/kg.d, and the administration lasts for 28 days. The dosage for human use can be determined by conversion.
Based on the above, the astragalus seed protein can be applied to anti-exercise fatigue functional food, and can be used as a nutritional supplement for exercise fatigue caused by overlarge exercise amount and extreme exercise in the field of competitive exercise and the field of public fitness;
the type of the anti-sports fatigue functional food comprises biscuits, liquid beverages, solid beverages and the like.
Compared with the prior art, the invention has the following advantages and effects:
1. the astragalus seed protein is prepared by an ammonium sulfate saturation precipitation method, and the saturation of the ammonium sulfate is 30-80%. Can be used as nutritional supplement for resisting sports fatigue, and can be added into cookies, liquid beverage, and solid beverage, with convenient use, and can satisfy sports people who like different food types.
2. The astragalus seed protein of the invention is unrelated to stimulant, and does not belong to or contain a compound forbidden by the international Olympic Commission.
3. The astragalus seeds have wide sources, sufficient medicinal materials are supplied, the protein content is rich, the extraction and separation method is mature, and the method is easy to popularize and apply industrially.
Detailed Description
The present invention will be described in further detail with reference to examples, but the embodiments of the present invention are not limited thereto.
Example 1
An extraction and separation method of astragalus seed protein comprises the following steps:
(1) pulverizing radix astragali seed, defatting with petroleum ether, and adding KH2PO4Stirring and leaching the solution with NaOH buffer solution for 6 to 12 hours, centrifuging, and taking supernatant; repeating the above leaching operation for 2-3 times, and mixing the obtained supernatants to obtain extractive solution;
(2) slowly adding powdered ammonium sulfate into the extractive solution under stirring to 30% saturation, centrifuging, and collecting supernatant; slowly adding powdered ammonium sulfate into the supernatant under continuous stirring to reach 40% saturation, centrifuging, and collecting precipitate;
(3) transferring the precipitate into dialysis bag, dialyzing in deionized water (changing water every 24 hr on average) until the dialysate is colorless, and freeze drying the components in the dialysis bag to obtain radix astragali seed protein.
Example 2
A method for extracting and separating astragalus membranaceus seed protein adopts an ammonium sulfate saturation precipitation method, and also comprises 3 steps, wherein the steps (1) and (3) are the same as those in example 1, and the step (2) is as follows:
(2) slowly adding powdered ammonium sulfate into the extractive solution under stirring to reach 40% saturation, centrifuging, and collecting supernatant; and slowly adding powdery ammonium sulfate into the supernatant to reach 60% of saturation degree under continuous stirring, centrifuging, and collecting precipitate.
Example 3
A method for extracting and separating astragalus membranaceus seed protein adopts an ammonium sulfate saturation precipitation method, and also comprises 3 steps, wherein the steps (1) and (3) are the same as those in example 1, and the step (2) is as follows:
(2) slowly adding powdered ammonium sulfate into the extractive solution under stirring to reach saturation of 60%, centrifuging, and collecting supernatant; and slowly adding powdered ammonium sulfate into the supernatant to reach the saturation of 80% under continuous stirring, centrifuging, and collecting the precipitate.
Comparative example 1
An extraction and separation method of astragalus seed protein adopts an ammonium sulfate saturation precipitation method, and the saturation of ammonium sulfate fractional precipitation is less than 30%; the other steps are the same as in example 1.
Comparative example 2
An extraction and separation method of radix astragali seed protein adopts ammonium sulfate saturation precipitation method, wherein the saturation of ammonium sulfate fractional precipitation is more than 80%; the other steps are the same as in example 1.
Functional effect experiment:
healthy C57BL/6 mice were obtained, male, 8 weeks old, and 20-23g in body weight. A blank control group and an astragalus seed protein group are provided, and each group contains 30 mice. Raising at 23 + -2 deg.C and relative humidity of 55 + -5%, and setting light/dark at 12h/12h day and night cycle. The conventional feed is given every day, and the bedding materials are changed 2-3 times in 1 week after free feeding and water feeding. The astragalus membranaceus seed proteome is used for administering the proteins of each embodiment and each proportion, and the dosage is 0.5-2g/kg.d (see the table 1 in detail); the blank control group was given physiological saline for 28 days. Each group of mice underwent 3 passive swimming sessions for 15 minutes per week. And (4) killing after the last passive swimming experiment, and detecting related indexes. SPSS 17.0 statistical software is adopted to analyze experimental data, and results are obtainedShowing that the samples between groups are compared by adopting one-way analysis of variance.
Detection of swimming exhaustion time: 10 mice were taken out of each group for passive swimming experiments. The temperature of the swimming pool water is kept at 26 +/-1 ℃ and the water depth is 35 cm. A weight with the mass of 10 percent of the mouse body is added on the tail of each mouse. From the beginning of the experiment, the mice are judged to have exhausted movement when the coordinated movement disorder occurs and the water surface can not be exposed within 10s, and the swimming time of the mice is recorded. The results are shown in Table 2.
Detecting blood biochemical indexes: 10 mice are taken out from each group, the weight bearing (2 percent of the weight of the mice) is firstly carried out for 30min swimming movement, blood is collected after the rest for 60min, and the blood lactic acid content and the blood urea nitrogen content are measured by adopting a kit of Nanjing institute of bioengineering. The results are shown in Table 3.
Tissue glycogen analysis: the rest 10 mice in each group firstly do swimming exercise without load for 90min, after resting for 60min, the mice are killed, the liver and gastrocnemius are taken, and the concentration of hepatic glycogen and myoglycogen is detected by adopting a kit of Nanjing institute of bioengineering. The results are shown in Table 4.
The exhaustion time is the comprehensive manifestation of various functions of the body such as anti-stress capability, anti-fatigue capability and the like, and is an important direct index for measuring the motor capacity of the body. Swimming is forced whole body consumption exercise, a large amount of energy is consumed by violent exercise, and the swimming time is comprehensively reflected by the physiological activity of the organism, so the swimming exhaustion time is one of important indexes for measuring the sports fatigue.
Lactic acid is one of the most studied sports fatigue-causing substances at present, and during aerobic exercise, the organism produces little lactic acid, but under the condition of oxygen deficiency, glycogen is subjected to anaerobic decomposition to produce a large amount of lactic acid. With the increase of the exercise intensity, the yield of lactic acid in the organism is obviously increased. The increase in lactic acid can cause a decrease in exercise capacity through a variety of pathways: on the one hand, the lactic acid dissociation generates a large amount of H+The key enzyme of glycolysis is inhibited, so that the anaerobic oxidation energy supply of sugar is reduced, the synthesis of ATP during exercise is reduced, and the exercise capacity is reduced; on the other hand, H formed after dissociation of lactic acid+To decouple excitation-contraction, which results in the reduction of skeletal muscle contraction and reduced exercise capacity. The concentration of the blood lactic acid is increased during the sports fatigue, so the content change of the blood lactic acid after the astragalus seed protein is applied to the mice can reflect the anti-sports fatigue effect of the mice.
There are three main causes of elevated blood urea nitrogen caused by exercise: (1) the alanine-glucose circulation is enhanced, and the urea is increased; (2) the motor enhances the aging decomposition of the enzyme in the muscle, and the urea which is the final product of the catabolism is increased; (3) muscle is rapidly supplied with energy, ATP cannot be rapidly synthesized, AMP is generated, AMP is easy to deaminate in muscle to generate IMP, and ammonia is converted into urea. Research shows that blood urea nitrogen is an important index of sports fatigue, and the higher the content of the blood urea nitrogen is, the poorer the exercise endurance of the organism is.
Sugar is a main energy supply substance when a body moves, the existing mode in the body is blood sugar and glycogen, glycogen is a storage form of sugar, and 2 forms of liver glycogen and muscle glycogen are mainly used for maintaining the stability of blood sugar and meeting the energy requirement of skeletal muscle during movement, and is closely related to the occurrence of sports fatigue. Energy in exercise is derived from the breakdown of glycogen, muscle glycogen is first consumed in strenuous exercise, and then energy is obtained from glucose which is continuously released into the blood from liver glycogen. Therefore, the glycogen content of the body is a sensitive index for judging the sports fatigue.
As can be seen from the experimental results (Table 2, Table 3 and Table 4), administration of the astragalus seed protein of comparative example 1 had no effect on the swimming exhaustion time, blood lactic acid content, blood urea nitrogen content, liver glycogen and muscle glycogen concentrations of the mice, compared to the control group. Likewise, administration of the astragalus seed protein of comparative example 2 had no effect on the time to swimming exhaustion, blood lactate content, blood urea nitrogen content, liver glycogen and muscle glycogen concentrations in the mice. The prepared astragalus seed protein with the saturation of less than 30 percent and more than 80 percent of ammonium sulfate has no sports fatigue resistance effect and can not be used as a nutritional supplement for resisting sports fatigue.
However, administration of the astragalus seed proteins of examples 1-3 to each group of mice very significantly extended the time to swim exhaustion, very significantly reduced the blood lactate and blood urea nitrogen levels, and very significantly increased the liver glycogen and muscle glycogen concentrations, as compared to the control group. The obtained astragalus seed protein with 30-80% of saturation of ammonium sulfate has the effect of resisting sports fatigue and can be used as a nutritional supplement for resisting sports fatigue.
TABLE 1 saturation of ammonium sulfate fractional precipitation and experimental dosing of seed protein to Astragalus membranaceus
P <0.01 compared to control group.
P <0.01 compared to control group.
P <0.01 compared to control group.
The above embodiments are preferred embodiments of the present invention, but the present invention is not limited to the above embodiments, and any other changes, modifications, substitutions, combinations, and simplifications which do not depart from the spirit and principle of the present invention should be construed as equivalents thereof, and all such changes, modifications, substitutions, combinations, and simplifications are intended to be included in the scope of the present invention.
Claims (5)
1. The application of the astragalus seed protein in the anti-sports fatigue functional food is characterized in that:
the method for extracting and separating the astragalus seed protein comprises the following steps:
(1) pulverizing radix astragali seed, defatting with petroleum ether, and adding KH2PO4Stirring and leaching the solution with NaOH buffer solution for 6 to 12 hours, centrifuging, and taking supernatant; repeating the above leaching operation for several times, and mixing the obtained supernatants to obtain extractive solution;
(2) adding powdered ammonium sulfate into the extractive solution under stirring to 30% saturation, centrifuging, and collecting supernatant; adding powdered ammonium sulfate into the supernatant under continuous stirring to reach 80% saturation, centrifuging, and collecting precipitate;
(3) transferring the precipitate into a dialysis bag, dialyzing in deionized water until the dialysate is colorless, and freeze-drying the components in the dialysis bag to obtain astragalus seed protein;
the operation is carried out in an environment of 4-10 ℃.
2. Use according to claim 1, characterized in that: the petroleum ether degreasing in the step (1) is to hermetically soak the astragalus seed powder for 2 to 4 hours by using petroleum ether, and air-dry the astragalus seed powder after filtering.
3. Use according to claim 1, characterized in that: KH in the step (1)2PO4NaOH buffer, concentration 40mmol/L, pH 6.8-8.0.
4. Use according to claim 1, characterized in that: the centrifugation in the step (2) is 2000-3000r/min and the centrifugation is 8-15 min.
5. Use according to claim 1, characterized in that: the functional food for resisting sports fatigue comprises biscuits, liquid beverages and solid beverages.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710580674.7A CN107325163B (en) | 2017-07-17 | 2017-07-17 | Astragalus seed protein and application thereof in anti-sports fatigue functional food |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710580674.7A CN107325163B (en) | 2017-07-17 | 2017-07-17 | Astragalus seed protein and application thereof in anti-sports fatigue functional food |
Publications (2)
Publication Number | Publication Date |
---|---|
CN107325163A CN107325163A (en) | 2017-11-07 |
CN107325163B true CN107325163B (en) | 2020-06-16 |
Family
ID=60227125
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710580674.7A Active CN107325163B (en) | 2017-07-17 | 2017-07-17 | Astragalus seed protein and application thereof in anti-sports fatigue functional food |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107325163B (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW201934132A (en) * | 2018-02-13 | 2019-09-01 | 元進莊企業股份有限公司 | Use of poultry crude protein extract for preparing anti-fatigue composition |
CN113214351B (en) * | 2021-04-09 | 2021-11-30 | 华南师范大学 | Fenugreek protein, separation and extraction method thereof and application of fenugreek protein in preparation of bone marrow HSC (human serum albumin) removal auxiliary agent |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4618495A (en) * | 1982-08-25 | 1986-10-21 | Tsumura Juntendo Inc. | Preparation for reducing cancer symptoms without treating cancer |
CN1687115A (en) * | 2005-03-25 | 2005-10-26 | 中国农业大学 | Agglutinin protein of astragalus root and preparation method thereof |
CN1772036A (en) * | 2005-11-03 | 2006-05-17 | 上海中医药大学 | Application of astragalus extract in preparing antifatigue medicine |
CN101962402A (en) * | 2009-07-23 | 2011-02-02 | 山西中医学院 | Astragalus membranaceus glycoprotein as well as preparation method and usage thereof |
CN103450354A (en) * | 2009-07-23 | 2013-12-18 | 山西中医学院 | Huangqi glycoprotein (HQGP) and preparation method and application thereof |
WO2017128096A1 (en) * | 2016-01-26 | 2017-08-03 | 山西中医学院 | Radix astragali glycoprotein and preparation method and use thereof |
-
2017
- 2017-07-17 CN CN201710580674.7A patent/CN107325163B/en active Active
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4618495A (en) * | 1982-08-25 | 1986-10-21 | Tsumura Juntendo Inc. | Preparation for reducing cancer symptoms without treating cancer |
CN1687115A (en) * | 2005-03-25 | 2005-10-26 | 中国农业大学 | Agglutinin protein of astragalus root and preparation method thereof |
CN1772036A (en) * | 2005-11-03 | 2006-05-17 | 上海中医药大学 | Application of astragalus extract in preparing antifatigue medicine |
CN101962402A (en) * | 2009-07-23 | 2011-02-02 | 山西中医学院 | Astragalus membranaceus glycoprotein as well as preparation method and usage thereof |
CN103450354A (en) * | 2009-07-23 | 2013-12-18 | 山西中医学院 | Huangqi glycoprotein (HQGP) and preparation method and application thereof |
WO2017128096A1 (en) * | 2016-01-26 | 2017-08-03 | 山西中医学院 | Radix astragali glycoprotein and preparation method and use thereof |
Non-Patent Citations (2)
Title |
---|
A novel homodimeric lectin from Astragalus mongholicus with antifungal activity;Qiaojuan Yan et al.,;《Archives of Biochemistry and Biophysics》;20050815;第442卷;第72–81页 * |
膜荚黄芪种子中2种几丁质酶的分离纯化及活性测定;费凡 等;《西北植物学报》;20091231;第29卷(第12期);第1.2.1,1.2.2,1.2.3节 * |
Also Published As
Publication number | Publication date |
---|---|
CN107325163A (en) | 2017-11-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN100335107C (en) | Health medicinal wine | |
CN101530196B (en) | Food formula of special diet containing oligopeptides for postoperative patient | |
CN102512655B (en) | L-carnitine composition, L-carnitine preparation and preparation method and application thereof | |
CN105288578A (en) | Preparation with fatigue relieving function | |
CN108606269B (en) | Sports nutritional supplement and preparation method thereof | |
CN107080198A (en) | A kind of date-wolfberry fruit walnut composite chewable tablet and preparation method thereof | |
CN111035649A (en) | NMN + GLP compound nutritional supplement and preparation method and application thereof | |
CN106244371A (en) | A kind of blood sugar lowering Rhizoma Polygonati grape health care wine and production technology thereof | |
CN107212401A (en) | Composition for relieving physical fatigue and its preparation and preparation method | |
CN104855975A (en) | Non-total-nutrient formula food for sarcopenia syndrome | |
KR101002774B1 (en) | The invigorate energy food which is made from herb medicine and the producing method thereof | |
CN107325163B (en) | Astragalus seed protein and application thereof in anti-sports fatigue functional food | |
CN107897908A (en) | A kind of breakfast suitable for weight-reducing reconstitutes food therapeutic composition and preparation method thereof | |
CN102657304B (en) | Health-care food with double functions of promoting digestion and relieving physical fatigue | |
CN104544400A (en) | Preparation method for compound health drink containing aweto extractive | |
CN106579419A (en) | Fatigue alleviating, physical strength restoring and energy replenishing functional food composition | |
KR20170116532A (en) | Maca and date palms, Ganoderma lucidum, perform exercises containing fermented antler extract as an active ingredient skills enhancement and promotion fatigue complex composition | |
CN107410816A (en) | One kind helps positive complement medical and edible dual purpose plant spy's dietary seafood | |
CN111467468A (en) | Concentrated nutrient solution containing ginseng, cordyceps militaris, ginger and wolfberry fruit and preparation method thereof | |
CN1401758A (en) | Process for preparing dietetic health vinegar, and dietetic heath vinegar produced thereby | |
CN102451260A (en) | Traditional Chinese medicine composition with function of alleviating fatigue and preparation method thereof | |
CN105341612A (en) | Herbal energy solid drink and preparation method and use thereof | |
CN104587425A (en) | Cold-dispelling paste traditional Chinese medicine composition and preparation method thereof | |
CN109527577A (en) | A kind of composition with sobering up and liver protecting functions | |
CN101983721B (en) | Desert cistanche calcium composition having functions of fatigue resistance and calcium supplement |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |